grepcent / static financial knowledge base

Informational only - not investment advice.

SIC 2835 - In Vitro & In Vivo Diagnostic Substances

Division: Manufacturing. Major group: Chemicals And Allied Products. As of: 2026-02-20.

Companies

Macro Context

Sector financials

Peer figures are build-time aggregates of the SEC companyfacts financials already shown on member company pages. As of latest member filing date: 2026-02-20.

N = 1 member companies with financial data; n too small for median peer statistics.

Companies With DataCompanies With RevenueAggregate Revenue
114,303,702,000

Peer Table

CompanyLatest RevenueRevenue FYNet MarginOperating MarginRevenue GrowthDiluted EPS
IDXX - IDEXX LABORATORIES INC /DE4,303,702,000202524.62%31.60%10.42%13.08

Sources

Macro Data

SEC Data